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significant role in producing variability of the PKD1 sequenceThirteen novel mutations of the replicated region of PKD1 in
in this population. The identification of additional mutationsan Asian population.
will help guide the study of polycystin-1 and better help us toBackground. Mutations of PKD1 are thought to account for
understand the pathophysiology of this common disease.approximately 85% of all mutations in autosomal dominant
polycystic kidney disease (ADPKD). The search for PKD1
mutations has been hindered by both its large size and compli-
cated genomic structure. To date, few mutations that affect
The most common and severe form of autosomal dom-the replicated segment of PKD1 have been described, and
inant polycystic kidney disease (ADPKD) develops asvirtually all have been reported in Caucasian patients.
Methods. In the present study, we have used a long-range a consequence of mutations of PKD1. The gene encodes
polymerase chain reaction (PCR)-based strategy previously a 14 kb mRNA that is derived from 46 exons, which
developed by our laboratory to analyze exons in the replicated extend over approximately 53 kb of genomic DNA [1–4].
region of PKD1 in a population of 41 unrelated Thai and 6
Its protein product, polycystin, is 4302 amino acids inunrelated Korean families with ADPKD. We have amplified
length and is likely to be a membrane-associated glyco-approximately 3.5 and approximately 5 kb PKD1 gene-specific
fragments (59MR and 59LR) containing exons 13 to 15 and protein with multiple membrane-spanning segments.
15 to 21 and performed single-stand conformation analysis Both the size of the PKD1 mRNA and its gene product
(SSCA) on nested PCR products. are among the largest reported to date. It has been hy-
Results. Nine novel pathogenic mutations were detected, in-
pothesized that polycystin functions as a receptor forcluding six nonsense and three frameshift mutations. One of the
cell–cell or cell–matrix interactions, but direct evidencedeletions was shown to be a de novo mutation. Four potentially
pathogenic variants, including one 3 bp insertion and three supporting the model is lacking. The few functional stud-
missense mutations, were also discovered. Two of the noncon- ies that have been reported to date have involved over-
servative amino acid substitutions were predicted to disrupt expression of the C terminus of the protein [5, 6].
the three-dimensional structure of the PKD repeats. In addi-
Important clues to a protein’s functional propertiestion, six polymorphisms, including two missense and four silent
often are deduced by introducing mutations (either ran-nucleotide substitutions, were identified. Approximately 25%
of both the pathogenic and normal variants were found to be domly or in a targeted fashion) and assessing their impact
present in at least one of the homologous loci. on the protein activity. One unique property of genetic
Conclusion. To our knowledge, this is the first report of muta- diseases is that nature has already provided a mutated
tion analysis of the replicated region of PKD1 in a non-Cauca-
form of the gene’s sequence along with a phenotypicsian population. The methods used in this study are widely
readout. Mutation studies of affected individuals there-applicable and can be used to characterize PKD1 in a number
fore provide a database of allelic variants that can beof ethnic groups using DNA samples prepared using standard
techniques. Our data suggest that gene conversion may play a used to guide the study of important functional domains.
Missense mutations that appear to cause disease are par-
ticularly instructive in that they identify essential amino
Key words: polycystic kidney disease, long range polymerase chain
acid residues and critical functional elements. Equallyreaction, gene conversion, ADPKD, heredity, nonsense mutations,
Thai PKD1, Korean PKD1. important is the discovery of allelic variants that function
as modifiers of disease expression.Received for publication November 15, 1999
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ity of the complete genomic structure for more than four markers: SM7, CW3, 16AC2.5, or CW4, SM6, and KG8
[29–32]. Samples from 50 healthy Thai blood donorsyears (The Human Gene Mutation Database Cardiff,
http://www.uwcm.ac.uk/uwcm/mg/hgmd0.html) [1, 7–21]. served as normal controls.
This observation is even more remarkable if one consid-
Long-range polymerase chain reactioners the fact that almost all of the published studies have
focused on the 39 end of PKD1, a segment of the gene The long-range (LR) polymerase chain reaction (PCR)
products were generated using 300 to 400 ng of genomicestimated to be mutated in only 10 to 20% of all PKD1
individuals. The primary reason for the relative paucity DNA as template. Genomic DNA was isolated from ei-
ther fresh or frozen whole blood that had been stored forof data is the complicated genomic structure of PKD1
that greatly hinders its study. Relevant features include: up to five years. The DNA was extracted using either com-
mercially available kits (Puregene, Gentra, Research(1) high cytidine and guanosine (CG) content, (2) lengthy
coding sequence (.13 kb), (3) at least three nearly iden- Triangle Park, NC, USA) or standard phenol-chloroform
methods. The 59MR (approximately 3.5 kb) was amplifiedtical transcribed homologues that have a .95% sequence
similarity extending over 70% of the PKD1 gene’s length, using PKD1-specific primer (F26, 59-AGCGCAACTAC
TTGGAGGCCC-39) located in exon 15 and primer (R2,and (4) the presence of an unusual element within the
middle of the gene that contains an approximate 2.5 kb 59-GCAGGGTGAGCAGGTGGGGCCATCCTA-39)
located in intron 21 prior to the polypyrimidine tract insegment composed of 96% polypyrimidines (ppyr) on
its coding stand [22]. Several strategies have been used that intron (Fig. 1A). 59LR (approximately 5.0 kb) was
amplified from 400 ng of genomic template using primersby various groups to overcome these obstacles [7, 9, 23].
A second limitation of the published literature is that (F13, 59-TGGAGGGAGGGACGCCAATC-39) located
in intron 12 and primer (R27, 59-GTCAACGTGGGCCall previous reports of mutations in the replicated region
of PKD1 have focused on Caucasian families, even though TCCAAGT-39) located in exon 15.
59MR LR PCR amplification was performed as followsADPKD affects all ethnic and racial groups. It is widely
recognized that a broad sampling of ethnically distinct in a Perkin Elmer 9600 thermal cycler: denaturation at
958C for 3 minutes followed by 35 cycles at 958C for 20groups can help define the significance of disease-associ-
ated variants. It has been previously observed in other seconds and 708C for 4 minutes and 30 seconds and final
extension at 728C for 10 minutes. The total PCR volumedisorders, for example, that variants initially thought to
be pathogenic in one population were subsequently deter- was 50 mL using 4 U of rTth DNA polymerase XL (Cetus;
Perkin Elmer, Norwalk, CT, USA) and final MgOAC2mined to be normal variants in a second, ethnically distinct
population [18, 24–26]. Similarly, one of the missense concentration of 1.1 mmol/L. For 59LR, the long-range
PCR amplification was performed as follows: denatur-changes of PKD1 that we had discovered in an African
American individual with ADPKD was not detected in ation at 958C for 3 minutes and 15 seconds, 35 cycles at
958C for 20 seconds and at 688C for 7 minutes, and a.160 Caucasian chromosomes, but was present in the
homozygous state in an African-Caribbean patient [8]. final extension at 728C for 10 minutes. The PCR reaction
mix was the same as that described for 59MR, exceptIn this communication, we report the study of PKD1
mutation in a set of Thai and Korean families. We have that the final MgOAC2 concentration was 0.8 mmol/L. A
hot start protocol, as recommended by the manufacturer,focused the search on exons in the replicated region of
PKD1 near the polypyrimidine tract located in intron was used for the first cycle of amplification. Products of
the LR PCR reaction were run on a 1% agarose gel to21, since it had been previously hypothesized that this
element might be responsible for the gene’s apparent confirm that the reaction was successfully amplified. The
specificity of the 59MR and 59LR templates were verifiedmutability [27].
using strategies reported previously [8].
METHODS Single-stand conformation analysis
Human subjects The LR templates were serially diluted to (1:104 or 1:105)
to remove genomic contamination and then used as tem-Forty-one Thai and six Korean ADPKD families par-
ticipated in this study. The clinical diagnosis of ADPKD plate for nested PCR of 200 to 400 bp exonic fragments.
Intron-based primers were positioned approximately 30was assigned according to the criteria of Ravine et al
[28]. Family members of probands were recruited to to 50 bp away from consensus splice sites. In the case
of exons .400 bp in length (that is, exon 15), we designedparticipate after receiving his or her permission. Blood
samples were obtained after receiving informed consent primers that yielded a set of slightly overlapping frag-
ments that spanned the region of interest. A total of 23and were in accordance with institutional guidelines. The
majority of families were too small to establish linkage to primer pairs was used to amplify all exonic sequences
from exons 13 to 15. The primer sequences and PCReither PKD1 or PKD2 markers, but the 15 largest had
lod scores .1.0, with at least one of the following PKD1 conditions have been previously described [8]. Two mi-
Phakdeekitcharoen et al: Mutations of PKD1 in Asian population1402
Fig. 1. (A) The genomic structure of PKD1. The replicated portion of the gene begins with exon 1 and is thought to end in exon 34 (open
rectangle) [1]. The approximate position of the two PKD1-specific LR PCR products (59MR and 59LR) along with the primers used to amplify
them is indicated. The positions of the polypyrimidine tracts of approximately 2.5 kb and 0.5 kb, respectively, in intron 21 and 22 is identified by
“. . . TCCT . . .”. (B) Predicted structure of polycystin-1. The position and identification of each pathogenic and probable mutation found in this
study is as indicated. LDL, low-density lipoprotein; Ig, immunoglobulin; REJ, receptor for egg-jelly in the sperm of the sea urchin; Del, deletion;
and Ins, insertion.
croliters of LR were used as template for amplification intentional mismatches that introduced a restriction site
in an allele-specific manner. Briefly, we noted that theof each exon. The total PCR volume was 30 mL using
0.2 mL of dCTP and a final MgCl2 concentration of 1.5 enzyme, SpeI, recognizes a sequence (A/CTAGT) simi-
lar to the one affected by the exon 17 mutation (N 5mmol/L. After heat denaturation in 95% formamide
buffer, the products were separated by electrophoresis CCAAGC and M 5 CCAAGT). By intentionally in-
troducing two mismatches (C . A and A . T) and pos-on an 8% polyacrylamide gel containing 5% glycerol at
450 V for 16 hours at room temperature, dried, and itioning the primer adjacent to the putative mutation,
the primer (CTCAATTGCAGCAGCGGCTACTAG)placed on X-Omat XAR film (Kodak, Rochester, NY,
USA) and visualized by autoradiography [33]. Aber- could be used in combination with the exon 17 reverse
primer to produce a 64 bp product that was cleavablerantly migrating bands detected by single-stand confor-
mation analysis (SSCA) were cut from the gel and eluted by SpeI only if it contained the C7415T mutation.
into 100 mL of sterile water overnight. The eluted prod-
Test for segregationucts were reamplified using the same set of primers,
purified using Centricon-100 columns (Amicon, Beverly, When possible, the corresponding fragment was am-
plified from the DNA of other family members and wasMA, USA), and then sequenced. In cases in which the
sequence of exons with variant SSCA patterns could tested for the variant by restriction analysis. In cases in
which we were unable to show that a missense change af-not be determined unambiguously (that is, deletions and
insertions), the exons were cloned into pCRII (TA Clon- fected the normal haplotype (and thus be a normal vari-
ant), we tested for its presence in a panel of 50 normaling Kit; Invitrogen, Carlsbad, CA, USA) prior to 32P cycle
sequencing using a thermosequenase kit (Amersham, controls.
Arlington Heights, IL, USA).
Electronic database information
Restriction digests The following GenBank sequences (accessed at http://
www.ncbi.nlm.nih.gov/Web/Genbank) served as refer-When possible, mutations that were predicted to alter
a restriction site were confirmed by restriction enzyme ence files for these studies: L39891 for PKD1 genomic
nucleotide positions, L33234 for PKD1 cDNA positions,digestion analysis of reamplified products. In one case
(exon 17 mutation C7415T), the sequence variant did and AC002039 for the sequence of the homologous loci.
A complete listing of published PKD1 mutations can benot alter a restriction site, so we designed a primer with
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Fig. 1. (Continued)
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Table 1. Pathogenic mutation identified in PKD1 gene in the Thai population
Proband Exon Nucleic acid change Codon change Consequence Confirm enzyme In HC?
RAMA103–01a 13 Del 1 bp (G3336) FS after 1041 Frameshift Product cloned NT
RAMA36–01a 15 C5168T Q1653X Nonsense Pst I No
termination
RAMA77–01b 15 C6089T Q1960X Nonsense Sty I No
termination
RAMA32–01a 15 C6326T Q2039X Nonsense Bgl II No
termination
DA1 16 Del 7 bp (G7205-G7211) FS after 2331 Frameshift no enz., product cloned No
RAMA97–01a 17 C7415T R2402X Nonsense allele-specific primer1Spe I Yes (a2, b2, c1)
termination
RAMA99–01a 18 C7499T R2430X Nonsense Tsp45 I Yes (a1, b1, cNT)
termination
RAMA55–01a 19 C7883T Q2558X Nonsense Mae I No
termination
RAMA5–01a 21 Del 2 bp (C8159-T8160) FS after 2649 Frameshift Bsr I No
Abbreviations are: NT, not tested; HC, homologous copies of PKD1 (a 5 homolog genbank, b 5 Thai homolog genomic DNA, c 5 N23HA).
a Segregates with disease
b De novo mutation
Table 2. Probable pathogenic mutations
Proband Exon Nucleic acid change Codon change Consequence Confirm enzyme In HC?
RAMA49–01a 15 G3707A G1166S Missense Alu I No
RAMA108–01b 15 T6078A V1956E Missense allele-specific primer1Taq I No
RAMA96–02a 18 C7433T R2408C Missense Nla III Yes (a2, b1, cNT)
RAMA66–01b 18 Ins3bp (G7535-GCG-A7536) 2442 additional Gly Extra glycine no enz., product cloned NT
Abbreviations are: NT, not tested; HC, homologous copies of PKD1 (a 5 homolog genbank, b 5 Thai homolog genomic DNA, c 5 N23HA).
a Cannot test for segregation
b Segregates with disease
Table 3. Normal PKD1 variants identified in an Asian population
Nucleic acid
Proband Exon substitution Codon change Consequence Confirm enzyme Frequency % (x/y) In HC
RAMA96–02 15 G4885A T1558T Silent change TspR I 14 (13/94) No
RAMA4–01a 15 C6058T S1949S Silent change Mwo I 1 (1/92) No
RAMA61–01b 15 G6195A R1995H Missense Bsa AI 1 (1/90) No
RAMA99–02 17 T7376C L2389L Silent change Mva I 9 (9/95) Yes (a1, b1, c1)
RAMA41–01a 18 C7696T C2495C Silent change Csp6 I 1 (1/91) No
RAMA96–02b 20 G8021A D2604N Missense Sau3A I (cut NC) 1 (1/88) Yes (a2, b1, c2)
Abbreviations are: NC, normal control; HC, Homologous copies of PKD1 (a 5 homolog genbank, b 5 Thai homolog genomic DNA, c 5 N23HA); x/y, number
of samples having the variant/number of samples evaluated.
a Segregates with disease
b Does not segregate with disease
found at the Cardiff Human Gene Mutation Database Definite pathogenic mutations
(http://www.uwcm.ac.uk/uwcm/mg/hgmd0.html). The On- Variants predicted to severely alter the primary struc-
line Mendelian Inheritance in Man (OMIM) accession ture of polycystin-1 were defined as definite pathogenic
number for ADPKD is MIM173900 and MIM601313 for mutations. Nine of the variants fell within this category.
PKD1 (accessed at http://www.ncbi.nlm.nih). Each was either a nonsense mutation or an oligo-base
pair deletion predicted to result in a truncated protein
lacking the REJ domain, transmembrane-spanning re-RESULTS
gions, and the PKD1 C terminus (Table 1 and Fig. 1B).A total of 19 variants was detected in 16 families by
Six of the mutations were C to T transitions that resultedSSCA, and each could be grouped into one of three
in replacement of either an arginine (N 5 2) or glutaminegeneral categories: (1) definite pathogenic mutations
(N 5 4) with a nonsense codon. Two of the mutations(Table 1), (2) probable pathogenic mutations (Table 2),
involved a CpG dinucleotide, while the remainder alteredand (3) normal variants (Table 3). The details are de-
scribed in the following sections. a CA pair.
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Fig. 2. (A) De novo 7 bp deletion in exon
16. A DNA sequence analysis of the DA1
mutation. The mutant sequence is presented
on the left beside the corresponding normal
exon 16 sequence. The mutant allele has lost
one of the two tandemly arrayed copies of the
7 bp sequence, GCGGTCG [square brackets].
(B) The pedigree structure of family DA1.
The markers used to identify chromosome 16
haplotypes are listed in accordance with their
orientation on the chromosome (top-16ptel,
bottom 16pcen). The numbers below each
square (male) or circle (female) indicate al-
lelic variants at each genetic locus. The dis-
ease-associated haplotype is indicated by a
rectangular box. The filled circle identifies the
affected phenotype. (C ) Ethidium bromide-
stained 5% Nusieve agarose gel of exon 16
PCR product after digestion with restriction
enzyme BsrB I. This enzyme cleaves the 294
bp product into 2 fragments of 173 and 121
bp. The 7 bp deletion of exon 16 is solely
present in the single affected individual of
DA1. A marker lane (M) is on the far left,
adjacent to the exon 16 product of a normal,
unrelated individual (NC). The order of the
DA1 samples corresponds with that of the
pedigree as shown in B.
The remaining three pathogenic mutations were out- deletion in DAI involved one of the two copies of a
tandemly repeated 7 bp sequence in exon 16 (Fig. 2),of-frame deletions of 1, 2, and 7 bp, respectively. Each
of the deletions had involved repeated sequences. In the the 2 bp deletion in RAMA5 removed one of two copies
of a CT dinucleotide in exon 21 (Fig. 3).case of RAMA103, the single base-pair deletion removed
one C in a set of three Cs in exon 13. While the 7 bp Seven of the nine mutations in this category were
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Fig. 3. The RAMA5 2 bp deletion in exon
21. The sequence of the normal individual is
presented on the far left in the standard for-
mat. To highlight differences and facilitate
comparisons, each lane of normal sequence
was run beside the corresponding lane of mu-
tant sequence (G to G, A to A). The mutant
sequence has both the normal and mutant pat-
terns, since it was amplified using the LR prod-
uct as template. The mutant allele has deleted
one of the two tandemly arrayed copies of CT
present in normals.
proven to segregate with the disease phenotype. With 4). There are no known structural features of this part
of polycystin that can be used to assess how this insertionrespect to the other two mutations, one (C6089T) could
not be evaluated further because an insufficient number might affect the protein’s function. It is predicted to be
pathogenic since there are no known published examplesof samples were available from the family (RAMA77),
while the other was likely to be a de novo mutation. It of an amino acid insertion occurring mid-exon as a nor-
mal variant of polycystin. Moreover, previous reportswas found in the only affected individual in the family
(DA1; Fig. 2). Both parents, who are clinically normal, have also concluded that single amino acid insertions
are likely pathogenic in other diseases [35–38].were tested for the mutation, and neither had it. Like-
wise, neither of the unaffected siblings of the proband The last variant within this set was identified in a family
(RAMA96) that actually had two different, “private”had the mutation. The results of haplotype analyses with
a battery of microsatellite markers were consistent with missense changes (that is, not found in over 100 normal
chromosomes). The first variant (C7433T) was in exon 18the pedigree structure as presented in Figure 2 and pro-
vide further evidence that it was a de novo mutation. and substituted arginine (basic) for cysteine (nonpolar) at
position 2408. The second variant (G8021A) was in exon
Probable pathogenic mutations 20 and resulted in the replacement of aspartic acid
(acidic) by asparagine acid (uncharged polar). PedigreeFour of the variants found in affected individuals are
predicted to have only a modest effect on the primary analysis determined that the variants segregated inde-
pendently within the family (Fig. 5) and that the R2408Cstructure of polycystin (Table 2). They have features,
however, that suggest that they may be pathogenic. Each substitution segregated with disease. Furthermore, com-
parative analysis of murine and human polycystin-1 se-was unique to the family in which it was found and not
observed in a screen of over 100 normal chromosomes. quences revealed that R2408 is conserved between the
species (data not shown), suggesting a possible functionalMoreover, two of the variants could be shown to segre-
gate with the disease in the pedigree in which it was importance.
found (the other two could not be tested). Two of the
Normal variantsmutations (G1166S and V1956E) are amino acid substi-
tutions that are predicted to significantly alter the sec- We found six nucleotide substitutions that most likely
are normal variants because they either did not segregateondary structure of the protein based on recent nuclear
magnetic resonance (NMR) structural studies (discussed with the disease, were found in a panel of unaffected
individuals, or were silent nucleotide substitutions (Tablelater in this article). The third mutation [Ins3 bp(G7535-
GCG-A7536)] was a 3 bp in-frame insertion that is pre- 3). Included in this set are two missense mutations and
four silent nucleotide substitutions. One of the missensedicted to add an extra glycine [2442 additional Gly] (Fig.
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potentially have arisen by a similar mechanism. We used
three strategies to address this issue. First, we tested for
the presence of the variant in the DNA of the cell line,
N23HA. This rodent-human somatic cell hybrid has a
single chromosome 16 that lacks 16p13.3 as its only human
component [1, 39]. This cell line lacks PKD1 but has the
homologous loci. In parallel, we amplified the segment in
question using genomic DNA (not LR PKD1-specific
product) from five Thai individuals who lack the variant
as template. We included this group to control for possi-
ble subtle population differences in the sequence of the
homologous loci (N23HA was not derived from a Thai in-
dividual). Finally, once available, we tested for the pres-
ence of the variant in the two PKD1 homologues whose
sequence had been determined by the human genome
project (AC002039).
We found that two out of seven definite pathogenic
mutations, both nonsense mutations, are also present in
at least one homologue (Table 1). Likewise, one of the
four probable pathogenic mutations and two of the sixFig. 4. A 3 bp insertion in exon 18. P32-labeled cycle sequence analysis
normal variants, including the G8021A missense changeof exon 18 from an unaffected normal individual and the proband of
RAMA66. The mutant allele has a tandem duplication of the triplet, (D2604N), also are present in at least one homologue.
GCG. Interestingly, three of the changes (C7415T, R2402X;
C7433T, R2408C; G8021A, D2604N) are not found in
AC002039. In summary, a significant fraction of PKD1
changes, D2604N, had been described in a previous para- variants appears to be the result of either recurrent nu-
graph. The other missense variant, found in RAMA61, cleotide substitutions or gene conversion events.
results in a conservative substitution of histidine (basic)
for arginine (basic) and does not segregate with disease.
DISCUSSIONNeither missense change was found in any other pedi-
Most of the PKD1 mutations described in the litera-gree. Two of the four silent changes are unique to the
ture have been found in studies of Caucasian patients,pedigree in which they were found and segregate with
and the vast majority have been clustered in the 39,the disease. We cannot exclude the possibility based on
nonreplicated segment of PKD1 [12–21]. In our currentthe available data that these variants could be pathogenic
study, 41 unrelated Thai and 6 unrelated Korean familiesby affecting gene splicing in the region.
as well as 50 normal Thai controls were evaluated forTwo of the variants (G4885A in exon 15 and T7376C
mutations in the replicated region of PKD1. We foundin exon 17) are relatively common polymorphisms in the
13 novel pathogenic or probable pathogenic mutations,Thai population (14 and 9%, respectively). Both had
for a detection rate of 28% in the approximately 38%previously been identified in studies of a Caucasian pop-
of transcribed region of PKD1 gene that was studied.ulation [8, 10]. Interestingly, the T7376C polymorphism
The mutations were relatively evenly distributed overwas always observed to segregate with a second polymor-
the length of the duplicated region, although there wasphism in exon 18 [8] in the Caucasian population. In
a relative paucity of pathogenic changes involving exoncontrast, this variant was not observed in approximately
15 in this group [5 out of 13 mutations (38%) in 3.5/5190 Thai chromosomes, nine of which had the exon 17
kb of sequence (70%)]. In contrast to our original hy-T7376C variant. In addition, a pair of relatively common
pothesis, a clustering of mutations near the intron 21polymorphisms located in exons 20 and 21, which always
polypyrimidine tract was not observed.cosegregated in Caucasians [8], was not found in the
The pattern of mutation observed in this group differsThai population (.90 individuals).
somewhat from we [8] and others have previously found
PKD1 variants also present at homologous loci for the same segment of PKD1 (Cardiff PKD1 Mutation
Database http://www.uwcm.ac.uk/uwcm/mg/hgmd0.html).We have previously shown that a subset of PKD1
Interestingly, both our data and those in the PKD1 Muta-mutations and normal variants are likely the result of
tion Database were based on studies of Caucasian popu-gene conversion events between PKD1 and its homolo-
lations. As noted previously in this article, in the Thai/gous loci. In the current study, we tested whether any
of the new variants found in the Thai population could Korean dataset, we found a smaller proportion of muta-
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Fig. 5. A family with two unique missense
mutations, one of which segregates with dis-
ease. (A) Pedigree structure of RAMA96. (B)
NlaIII restriction digestion of exon 18. The
full-length, undigested PKD1-specific exon 18
PCR product of an unaffected individual
(Control 2, NC2) is 343 bp in length (lane 8)
and yields fragments of 243 bp and 100 bp
after NlaIII digestion (lane 7). The C7433T
mutation present in RAMA96 is predicted to
create a new NlaIII restriction site within the
100 bp segment that bisects it into fragments
of 60 and 40 bp. Affected family members II2
and II3 have the additional site (lanes 5, 6)
whereas an unaffected sibling II1 does not
(lane 4). In lanes 2 and 3, total genomic DNA
(rather than PKD1-specific LR products) of
two unrelated normal individuals (NC1 and
NC2) was used as template for the exon 18
amplification. Common to both individuals
are products of 343, 243, and 100 bp. NC2
(same individual as in lanes 7 and 8) has the
additional restriction site present in at least
one of his PKD1 homologues. Lane 1 is a
negative control amplification that contains
only water for template. (C ) Sau3AI restric-
tion digestion of exon 20. The sample order
is the same as in B. The full-length, undigested
PKD1-specific exon 20 product is 233 bp and
yields 122 and 111 bp fragments in unaffected
individuals (lanes 8 and 7, respectively). The
G8021A variant disrupts the Sau3AI site and
thus cannot be cleaved with this enzyme. In
RAMA96, multiple family members are het-
erozygous for this variant (lanes 4 through 6).
Since the variant is present in both unaffected
and affected individuals, it must be on the
normal 1-0-Q-8-4 haplotype. The variant also
is present in the genomic DNA of two normal
control samples (lanes 1 and 2) that did not
have the variant in their PKD1-specific exon.
This result shows that the variant is present
in at least one of the PKD1 homologues.
tions affecting exon 15 than had been observed in Cauca- ferences, however, since the trends persist even if one
counts the recurrent mutation as a single event rathersians [5 out of 13 vs. 9 out of 10 [8] and 7 out of 8 (Cardiff
Human Gene Mutation Database)]. Moreover, the type than three separate ones (P , 0.05).
An alternative reason is that the pattern of mutationof mutation also differed between the groups. In the
study by Watnick et al, 9 out of 10 pathogenic variants may truly differ between ethnic groups. This model sug-
gests that the mechanisms regulating the mutability ofwere frameshift mutations [8]. A similar pattern is re-
ported in the Cardiff database (6 out of 8). These data PKD1 may differ between ethnic groups. Specific as-of-
yet undefined chromosomal features peculiar to a par-are in contrast to the 3 out of 13 frameshifting mutations
described in this report. ticular ethnic group may influence the pattern and or
frequency of mutation within that group. The T3920AThere are several possible explanations for these dif-
ferences. First, the observed difference is simply caused mutation of Hereditary Non-polyposis Colorectal Can-
cer (HNPCC) found in Ashkenazi Jews is an exampleby chance. Although the number of samples is small, the
difference did reach statistical significance (Fisher Exact of such a property [40]. In the case of PKD1, perhaps
differences in the number of homologues, features of thetest, P , 0.05). Another potential confounding factor is
that three of the unrelated families in the study by Wat- polypyrimidine tracts or other PKD1 sequence variants
may serve such a function.nick et al were discovered to have an identical mutation
[8]. This variable is unlikely to account for all of the dif- A final possible explanation for the different muta-
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tional patterns that have been observed is that they are sessing their pathogenic significance. In the present study,
we found two different missense mutations (R2408C,the result of nonethnic differences between the groups.
The earlier study only included families that had individ- D2604N) in the DNA of an affected individual not found
in over 100 normal Thai chromosomes. Both are pre-uals with either early-onset disease or aneurysms. This
is in contrast to the present study, which included any dicted to result in nonconservative amino acid substitu-
tions that theoretically could result in disease. Only onefamily with ADPKD that was seen in clinic and whose
members agreed to participate. Only one of the Thai of them, however, segregated with the disease phenotype
in this family.families for whom we had identified the mutation had
an individual with an intracranial aneurysm (RAMA5), We also discovered two mutations that were noncon-
servative amino acid substitutions (G1166S, V1956E) in-and none had members with early onset disease. It is
possible that the type of mutation may correlate in some volving residues that form part of a domain (the PKD
domain) whose structure has recently been determinedway with the phenotype that is observed. The discovery
that three unrelated families in the Watnick et al study (Fig. 6) [42]. We used these data to assess the potential
impact of our missense mutations. The G1166S substitu-shared an identical, novel mutation is consistent with
this hypothesis [8]. Interestingly, RAMA5 had one of the tion involves PKD domain 5 within the CC9 loop region
(Fig. 6). The mutation occurs within the most conservedthree frameshifting mutations identified in the current
report. Further study of larger groups of affected individ- sequence of the PKD domains, WDFGDGS. The glycine
that is replaced (in bold) is the first residue of the turnuals will be required to determine the biological signifi-
cance of these findings. at the end of the C strand. Its replacement by the bulkier
serine is very likely to disrupt this structure.We had previously suggested that sequence variants
present in the PKD1 homologues may be introduced The V1956E mutation is similarly predicted to have
pathogenic consequences. It involves one of the two aminointo PKD1 via gene conversion events [41]. In more
recent work, we found that a significant fraction of the acid residues that comprise the FG turn of PKD domain
14. The structure of the FG turn is very highly conservednormal variants (6 out of 12) was also present in at least
one homologue [8]. In the current report, a relatively within the entire set of PKD domains, being only two
amino acid residues in length. In each, the second residuehigh fraction of both sets of variants (3 out of 13 muta-
tions and 2 out of 6 normal variants) had this property. is a large hydrophobic residue that is thought to partici-
pate in interdomain contacts with the preceding PKDThese data suggest that gene conversion events may be
an important mechanism of mutation in PKD1. How- domain. The substitution of a charged glutamic acid for
the nonpolar valine is highly likely to alter this structure.ever, we cannot exclude the possibility that at least a
subset of the variants are the result of recurrent muta- Based on these structural analyses, we predict that both
mutations are pathogenic but recognize that functionaltions that have altered one or more of the homologous
loci and PKD1. It is impossible to distinguish between studies will be required before we can prove this point.
These examples clearly illustrate the difficulty investi-these two possibilities with the available data.
One important novel finding is that some of the vari- gators face in establishing a diagnosis based on DNA
test results in this disease. Mutations that result in trunca-ants shown to be present in the homologues in the pres-
ent study were not found in the sequence of the two ho- tion of the protein or major rearrangements of the gene
can be readily identified as pathogenic and can be usedmologues that are in the database (AC002039). These
data illustrate the limitation of relying solely on AC002039 to base a diagnosis. It is presently unknown, however,
what proportion of PKD1 mutations will fall into thisas a reference file for the identification of PKD1-specific
sequence differences. The bacterial artificial chromo- class. Without a comprehensive DNA- and RNA-based
analysis of a very large number of individuals, it will besome (BAC) used to generate the sequence has only
two copies of the homologues, and it is known that there difficult to address this issue. “Private” missense changes
(defined as not found in more than one family in one’sis at least one more. Southern blot studies with probes
complementary to sequences of the replicated region of dataset) are common, and some proportion will, by
chance, segregate with disease in isolated families. Mo-PKD1 suggest there may be variability in the number
of copies as well (data not shown). The data presented lecular models may help in assessing the significance of
an amino acid substitution, but functional studies willin Figure 5B suggest that there is likely to be considerable
variability in the sequence of the homologues. In the likely be required to prove pathogenicity.
It is clear that far more DNA studies of multiple ethnicexample shown, one of the normal control samples had
the extra NlaIII restriction site, whereas the other did groups will be required before we can establish reliable
and specific DNA-based diagnosis for PKD1. The re-not. This study demonstrates the importance of using
multiple complementary strategies to prove the specific- agents described in this study should prove helpful to
others seeking to analyze the replicated region of PKD1ity of a PKD1 sequence.
The major challenge posed by missense variants is as- in their collection of patients. Virtually all of the DNA
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Fig. 6. Mutations G1166S and V1956E disrupt the secondary struc-
ture of the PKD1 domain. (A) The top row lists the seven b strands
(A–G) that form the two b sheets of the PKD1 domain as defined
by Bycroft et al [42]. The sequence of PKD domains 5 and 14 is
presented immediately below with the position of the missense muta-
tion of each indicated by a box. Regions that are thought to have
the same conformation as those of PKD domain 1 are shown in upper
case letters. Conservative residues are highlighted in bold type.
The most conserved sequence in the PKD domains is underlined
[42]. (B) Space-filling model of the first PKD domain (PKD-R1)
as determined by nuclear magnetic resonance spectroscopy (PDB
code: 1B4R) [42]. The G1166S mutation occurs in PKD-R5 at a
critical point in the PKD-R1 structure, G310, where a hairpin turn
is formed between bC and bC9. The replacement of glycine by
serine is likely to result in a protein folding error in the secondary
structure of PKD-R5. The second mutation (V1956E) occurs in
PKD-R14 and replaces a highly conserved aliphatic amino acid with
glutamic acid. The substitution occurs in the turn region between bF
and bG and lies in the likely interface region between PKD-R13
and PKD-R14. The aliphatic group is probably buried in this associ-
ation. Mutation of this valine to a negatively charged glutamic
acid is likely to have a broad impact on the tertiary structure and
associations of this region with its neighbors in space.
physicians who have supplied specimens and clinical information onsamples used in the present study were isolated using
their patients. G.G.G. is the Irving Blum Scholar of the Johns Hopkins
traditional phenol-chloroform DNA preparation meth- University School of Medicine. The authors thank Dr. Narin Hiransu-
thikul for statistic analysis and Dr. Klaus Piontek for many helpfulods and had been in storage for up to five years. With ad-
discussions and assistance in the production of this manuscript.ditional, well-placed PKD1-specific primers, it should soon
be possible to analyze the entire PKD1 gene in most DNA Reprint requests to Gregory G. Germino, M.D., Division of Nephrol-
ogy, Department of Medicine, Johns Hopkins University School of Medi-samples, including many that currently cannot be used for
cine, Ross 970, 720 Rutland Avenue, Baltimore, Maryland 21205, USA.LR PCR. These studies will ultimately lead to a clinically
E-mail: ggermino@welch.jhu.edu
useful DNA-based diagnostic test and a more comprehen-
sive understanding of the molecular basis of this disease.
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